Diagnosing model diagnostics

被引:446
作者
Karlsson, M. O. [1 ]
Savic, R. M. [1 ]
机构
[1] Uppsala Univ, Dept Pharmaceut Sci, S-75105 Uppsala, Sweden
关键词
D O I
10.1038/sj.clpt.6100241
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Conclusions from clinical trial results that are derived from model-based analyses rely on the model adequately describing the underlying system. The traditionally used diagnostics intended to provide information about model adequacy have seldom discussed shortcomings. Without an understanding of the properties of these diagnostics, development and use of new diagnostics, and additional information pertaining to the diagnostics, there is risk that adequate models will be rejected and inadequate models accepted. Thus, a diagnosis of available diagnostics is desirable.
引用
收藏
页码:17 / 20
页数:4
相关论文
共 9 条
[1]   Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide [J].
Brendel, Karl ;
Comets, Emmanuelle ;
Laffont, Celine ;
Laveille, Christian ;
Mentre, France .
PHARMACEUTICAL RESEARCH, 2006, 23 (09) :2036-2049
[2]   A population pharmacokinetic-pharmacodynamic analysis of repeated measures time-to-event pharmacodynamic responses: The antiemetic effect of ondansetron [J].
Cox, EH ;
Veyrat-Follet, C ;
Beal, SL ;
Fuseau, E ;
Kenkare, S ;
Sheiner, LB .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1999, 27 (06) :625-644
[3]  
Girard P, 1998, STAT MED, V17, P2313, DOI 10.1002/(SICI)1097-0258(19981030)17:20<2313::AID-SIM935>3.0.CO
[4]  
2-V
[5]  
Holford N., 2005, PAGE, V14
[6]  
HOOKER A, 2005, AAPS PHARM SCI, V7
[7]   Assumption testing in population pharmacokinetic models: Illustrated with an analysis of moxonidine data from congestive heart failure patients [J].
Karlsson, MO ;
Jonsson, EN ;
Wiltse, CG ;
Wade, JR .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1998, 26 (02) :207-246
[8]  
Savic R, 2006, AAPS J, V8
[9]   ESTIMATION OF POPULATION CHARACTERISTICS OF PHARMACOKINETIC PARAMETERS FROM ROUTINE CLINICAL DATA [J].
SHEINER, LB ;
ROSENBERG, B ;
MARATHE, VV .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1977, 5 (05) :445-479